TD Cowen analyst Boris Peaker downgraded MacroGenics (NASDAQ: MGNX) from Buy to Hold.The analyst comments "Efficacy was promising ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades

BMO Capital Downgrades MacroGenics (MGNX) to Market PerformMay 10, 2024 3:35 AM MacroGenics (MGNX) PT Lowered to $14 at BarclaysMay 10, 2024 3:26 AM Stifel Downgrades MacroGenics (MGNX) to HoldMay 10, 2024 2:42 AM MacroGenics (MGNX) PT Lowered to $16 at JMP SecuritiesMay 10, 2024 2:33 AM After-hours movers: Akamai Technologies, Unity, Macrogenics and moreMay 9, 2024 4:49 PM Macrogenics (MGNX) Misses Q1 EPS by 20cMay 9, 2024 4:33 PM Form 8-K MACROGENICS INC For: May 09May 9, 2024 4:08 PM Form 8-K MACROGENICS INC For: May 09May 9, 2024 4:07 PM Form 10-Q MACROGENICS INC For: Mar 31May 9, 2024 4:03 PM Macrogenics (MGNX) Provides Update on Corporate Progress, TAMARACK Phase 2 Study Data, Q1 ResultsMay 9, 2024 4:02 PM